300
Participants
Start Date
February 26, 2015
Primary Completion Date
May 9, 2017
Study Completion Date
May 9, 2017
TV-45070
TV-45070 is an ointment applied topically twice daily to area of pain.
Placebo
The matching placebo ointment contained only the excipients of the active treatment; also applied topically twice daily to area of pain.
Teva Investigational Site 13054, New York
Teva Investigational Site 13334, Brooklyn
Teva Investigational Site 13658, Albany
Teva Investigational Site 13327, Pittsburgh
Teva Investigational Site 13333, Levittown
Teva Investigational Site 13339, Philadelphia
Teva Investigational Site 13090, Norfolk
Teva Investigational Site 13082, Winston-Salem
Teva Investigational Site 13337, Raleigh
Teva Investigational Site 13060, Calabash
Teva Investigational Site 13332, Charleston
Teva Investigational Site 13063, Marietta
Teva Investigational Site 13053, Atlanta
Teva Investigational Site 13098, Jacksonville
Teva Investigational Site 13073, Orlando
Teva Investigational Site 13048, Orlando
Teva Investigational Site 13047, Hialeah
Teva Investigational Site 13659, Pembroke Pines
Teva Investigational Site 13046, Homestead
Teva Investigational Site 13064, Miami
Teva Investigational Site 13338, Miami
Teva Investigational Site 13513, Virginia Gardens
Teva Investigational Site 13044, Miami
Teva Investigational Site 13335, Miami
Teva Investigational Site 13521, Brandon
Teva Investigational Site 13059, Tampa
Teva Investigational Site 13519, Seminole
Teva Investigational Site 13056, St. Petersburg
Teva Investigational Site 13057, Clearwater
Teva Investigational Site 13084, Fort Myers
Teva Investigational Site 13522, Naples
Teva Investigational Site 13329, Venice
Teva Investigational Site 13085, Brooksville
Teva Investigational Site 13058, New Port Richey
Teva Investigational Site 13076, Oldsmar
Teva Investigational Site 13045, Kissimmee
Teva Investigational Site 13052, Birmingham
Teva Investigational Site 13086, Mobile
Teva Investigational Site 13095, Knoxville
Teva Investigational Site 13096, Memphis
Teva Investigational Site 13089, Columbus
Teva Investigational Site 13062, Evansville
Teva Investigational Site 13093, Evansville
Teva Investigational Site 13061, Detroit
Teva Investigational Site 13049, Farmington Hills
Teva Investigational Site 13068, Rapid City
Teva Investigational Site 13072, Bolingbrook
Teva Investigational Site 13091, Aurora
Teva Investigational Site 13099, St Louis
Teva Investigational Site 13660, Shreveport
Teva Investigational Site 13074, Monroe
Teva Investigational Site 13661, Little Rock
Teva Investigational Site 13075, Oklahoma City
Teva Investigational Site 13328, Oklahoma City
Teva Investigational Site 13516, Oklahoma City
Teva Investigational Site 13340, McKinney
Teva Investigational Site 13050, Plano
Teva Investigational Site 13070, Arlington
Teva Investigational Site 13088, Austin
Teva Investigational Site 13518, Salt Lake City
Teva Investigational Site 13514, Phoenix
Teva Investigational Site 13520, Phoenix
Teva Investigational Site 13066, Albuquerque
Teva Investigational Site 13065, Las Vegas
Teva Investigational Site 13051, Santa Monica
Teva Investigational Site 13100, Torrance
Teva Investigational Site 13055, Thousand Oaks
Teva Investigational Site 13331, Pomona
Teva Investigational Site 13079, Colton
Teva Investigational Site 13341, Sacramento
Teva Investigational Site 13078, Eugene
Teva Investigational Site 13081, Bellevue
Teva Investigational Site 13336, Seattle
Teva Investigational Site 13657, Milford
Teva Investigational Site 13094, Brockton
Teva Investigational Site 13330, Albuquerque
Teva Investigational Site 13083, North Massapequa
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY